- Tetrahydroisoquinoline compounds
-
The present invention provides a substituted aryl compound represented by the formula (I) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition and containing the same as PRMT5 inhibitor.
- -
-
-
- HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
- -
-
-
- HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Compounds and pharmaceutical compositions of formulae (I), (XI) and (XII) as PI3 kinase modulators and their use in the treatment of diseases such as cancer.
- -
-
Paragraph 00569
(2013/03/26)
-